Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Austin

Showing results (181-190 of 220) with videos related to

Pageof 22
Sort By:
Human Gene Therapy|September 30, 2020
The Platform Vector Gene Therapies Project: Increasing the Efficiency of Adeno-Associated Virus Gene Therapy Clinical Trial StartupPhilip J Brooks, Elizabeth A Ottinger, Deanna Portero, et al.
Drug Discovery Today|February 19, 2022
Defining clinical outcome pathwaysDaniel Korn, Andrew J Thieme, Vinicius M Alves, et al.
Nature Methods|May 4, 2021
A versatile polypharmacology platform promotes cytoprotection and viability of human pluripotent and differentiated cellsYu Chen, Carlos A Tristan, Lu Chen, et al.
Cell Reports|July 21, 2015
Genome-wide Analysis of Host-Plasmodium yoelii Interactions Reveals Regulators of the Type I Interferon ResponseJian Wu, Baowei Cai, Wenxiang Sun, et al.
Human Molecular Genetics|November 2, 2013
High-content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC-independent pathway in myotonic dystrophy cell linesAmi Ketley, Catherine Z Chen, Xin Li, et al.
Biochemistry|July 8, 2009
Identification of aminothienopyridazine inhibitors of tau assembly by quantitative high-throughput screeningAlex Crowe, Wenwei Huang, Carlo Ballatore, et al.
Environmental Health Perspectives|January 27, 2015
Population-based in vitro hazard and concentration-response assessment of chemicals: the 1000 genomes high-throughput screening studyNour Abdo, Menghang Xia, Chad C Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2012
Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFβ interactionLea Cunningham, Steven Finckbeiner, R Katherine Hyde, et al.
Plos One|November 14, 2013
A novel chordoma xenograft allows in vivo drug testing and reveals the importance of NF-κB signaling in chordoma biologyMatteo M Trucco, Ola Awad, Breelyn A Wilky, et al.
Antimicrobial Agents and Chemotherapy|November 7, 2012
A class of tricyclic compounds blocking malaria parasite oocyst development and transmissionRichard T Eastman, Sittiporn Pattaradilokrat, Dipak K Raj, et al.
Pageof 22

Showing results (181-190 of 220) with videos related to

Sort By:
Pageof 22
Human Gene Therapy|September 30, 2020
The Platform Vector Gene Therapies Project: Increasing the Efficiency of Adeno-Associated Virus Gene Therapy Clinical Trial StartupPhilip J Brooks, Elizabeth A Ottinger, Deanna Portero, et al.
Drug Discovery Today|February 19, 2022
Defining clinical outcome pathwaysDaniel Korn, Andrew J Thieme, Vinicius M Alves, et al.
Nature Methods|May 4, 2021
A versatile polypharmacology platform promotes cytoprotection and viability of human pluripotent and differentiated cellsYu Chen, Carlos A Tristan, Lu Chen, et al.
Cell Reports|July 21, 2015
Genome-wide Analysis of Host-Plasmodium yoelii Interactions Reveals Regulators of the Type I Interferon ResponseJian Wu, Baowei Cai, Wenxiang Sun, et al.
Human Molecular Genetics|November 2, 2013
High-content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC-independent pathway in myotonic dystrophy cell linesAmi Ketley, Catherine Z Chen, Xin Li, et al.
Biochemistry|July 8, 2009
Identification of aminothienopyridazine inhibitors of tau assembly by quantitative high-throughput screeningAlex Crowe, Wenwei Huang, Carlo Ballatore, et al.
Environmental Health Perspectives|January 27, 2015
Population-based in vitro hazard and concentration-response assessment of chemicals: the 1000 genomes high-throughput screening studyNour Abdo, Menghang Xia, Chad C Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2012
Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFβ interactionLea Cunningham, Steven Finckbeiner, R Katherine Hyde, et al.
Plos One|November 14, 2013
A novel chordoma xenograft allows in vivo drug testing and reveals the importance of NF-κB signaling in chordoma biologyMatteo M Trucco, Ola Awad, Breelyn A Wilky, et al.
Antimicrobial Agents and Chemotherapy|November 7, 2012
A class of tricyclic compounds blocking malaria parasite oocyst development and transmissionRichard T Eastman, Sittiporn Pattaradilokrat, Dipak K Raj, et al.
Pageof 22